Immunoassay Analyzers Market Revenue Report

Immunoassay Analyzers Market Revenue Analysis By Product (Chemiluminescence, Immunofluorescence Analyzers, Radioimmunoassay, Elisa), By Application (Oncology, Infectious Disease Testing, Autoimmune Disease), And Segment Forecasts To 2024

  • Published Date: Nov, 2016
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-992-0
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 85

Table of Contents

Chapter 1 Research Methodology
                    1.1 Information procurement
                    1.2 Data Analysis
                    1.3 Approaches for market estimation
                       1.3.1 Approach 1: Demand Analysis& Bottom up Approach
                       1.3.2 Approach 2: Top down market estimation
                       1.3.3 Approach 3: Commodity flow and bottom up market estimation
                       1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends& Scope
                    3.1 Market segmentation& scope
                       3.1.1 Market Driver Analysis
                             3.1.1.1 Demand for automated and portable immunoassay systems
                             3.1.1.2 Rising incidences of chronic and infectious diseases
                       3.1.2 Market Restraints Analysis
                             3.1.2.1 Low detection limit of existing technology
                             3.1.2.2 Implementation of excise duties by the U.S. government
                    3.2 Penetration & growth prospect mapping
                    3.3 Immunoassay Instruments - SWOT Analysis, By Factor (political & legal, economic and technological)
                    3.4 Industry Analysis - Porter’s
Chapter 4 Market Categorization 1: Product Estimates & Trend Analysis
                    4.1 Immunoassay Instruments Market: Product movement analysis
                    4.2 Chemiluminescence Immunoassay
                       4.2.1 Chemilumenscence Immunoasssay Market, 2014 - 2024 (USD Million)
                    4.3 Immunofluorescence analyzers
                       4.3.1 Immunofluorescence analyzers Market, 2014 - 2024 (USD Million)
                    4.4 Radioimmunoassay
                       4.4.1 Radioimmunoassay Market, 2014 - 2024 (USD Million)
                    4.5 Enzyme Linked Immunoassay(EIA)
                       4.5.1 Enzyme Linked Immunoassay Market, 2014 - 2024 (USD Million)
                    4.6 Consumables & Accessories
                       4.6.1 Consumables & Accessories Market, 2014 - 2024 (USD Million)
Chapter 5 Market Categorization 3: Application Estimates & Trend Analysis
                    5.1 Immunoassay Instruments Market: Application movement analysis
                    5.2 Therapeutics Drug Monitoring
                       5.2.1 Therapeutic Drug Monitoring Market, 2014 - 2024 (USD Million)
                    5.3 Oncology
                       5.3.1 Oncology Market, 2014 - 2024 (USD Million)
                    5.4 Cardiology
                       5.4.1 Cardiology Market, 2014 - 2024 (USD Million)
                    5.5 Endocrinology
                       5.5.1 Endocrinology Market, 2014 - 2024 (USD Million)
                    5.6 Infectious Disease Testing
                       5.6.1 Infectious Disease Testing Market, 2014 - 2024 (USD Million)
                    5.7 Autoimmune Disease
                       5.7.1 Autoimmune Disease Market, 2014 - 2024 (USD Million)
                    5.8 Others
                       5.8.1 Other Applications Market, 2014 - 2024 (USD Million)
Chapter 6 Market Categorization 4: Regional Estimates &Trend Analysis, by Product & Application type
                    6.1 North America
                       6.1.1 U.S.
                       6.1.2 Canada
                    6.2 Europe
                       6.2.1 U.K.
                       6.2.2 Germany
                    6.3 Asia Pacific
                       6.3.1 Japan
                       6.3.2 China
                    6.4 Latin America
                       6.4.1 Brazil
                       6.4.2 Mexico
                    6.5 Middle East and Africa (MEA)
                       6.5.1 South Africa
Chapter 7 Competitive Landscape
                    7.1 Market participation categorization
                    7.2 Company Profiles
                       7.2.1 bioMerieux. Inc
                             7.2.1.1 Company Overview
                             7.2.1.2 Financial Performance
                             7.2.1.3 Product Benchmarking
                             7.2.1.4 Strategic Initiatives
                       7.2.2 Abbott Laboratories
                             7.2.2.1 Company Overview
                             7.2.2.2 Financial Performance
                             7.2.2.3 Product Benchmarking
                             7.2.2.4 Strategic Initiatives
                       7.2.3 Roche Diagnostics
                             7.2.3.1 Company Overview
                             7.2.3.2 Financial Performance
                             7.2.3.3 Product Benchmarking
                             7.2.3.4 Strategic Initiatives
                       7.2.4 Diasorin S.p.A.
                             7.2.4.1 Company Overview
                             7.2.4.2 Financial Performance
                             7.2.4.3 Product Benchmarking
                             7.2.4.4 Strategic Initiatives
                       7.2.5 Beckman Coulter, Inc
                             7.2.5.1 Company Overview
                             7.2.5.2 Financial Performance
                             7.2.5.3 Product Benchmarking
                             7.2.5.4 Strategic Initiatives
                       7.2.6 Siemens Healthcare GmbH
                             7.2.6.1 Company Overview
                             7.2.6.2 Financial Performance
                             7.2.6.3 Product Benchmarking
                             7.2.6.4 Strategic Initiatives
                       7.2.7 Bio-Rad Laboratories Inc.
                             7.2.7.1 Company Overview
                             7.2.7.2 Financial Performance
                             7.2.7.3 Product Benchmarking
                             7.2.7.4 Strategic Initiatives
                       7.2.8 Becton Dickinson and Company
                             7.2.8.1 Company Overview
                             7.2.8.2 Financial Performance
                             7.2.8.3 Product Benchmarking
                             7.2.8.4 Strategic Initiatives
                       7.2.9 Sigma Aldrich.Co. LLC.
                             7.2.9.1 Company Overview
                             7.2.9.2 Financial Performance
                             7.2.9.3 Product Benchmarking
                             7.2.9.4 Strategic Initiatives
                       7.2.10 Boditech Med, Inc
                             7.2.10.1 Company Overview
                             7.2.10.2 Financial Performance
                             7.2.10.3 Product Benchmarking
                             7.2.10.4 Strategic Initiatives


List of Tables

TABLE 1 North America Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 2 North America Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 3 U.S. Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 4 U.S. Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 5 Canada Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 6 Canada Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 7 Europe Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 8 Europe Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 9 U.K. Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 10 U.K. Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 11 Germany Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 12 Germany Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 13 Asia Pacific Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 14 Asia Pacific Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 15 Japan Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 16 Japan Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 17 China Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 18 China Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 19 Latin America Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 20 Latin America Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 21 Brazil Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 22 Brazil Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 23 Mexico Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 24 Mexico Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)
TABLE 25 MEA Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 26 MEA Immunoassay Instruments, By Application, 2013 - 2014 - 2024 (USD Million)
TABLE 27 South Africa Immunoassay Instruments Market, By Product, 2014 - 2024 (USD Million)
TABLE 28 South Africa Immunoassay Instruments, By Application, 2014 - 2024 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Penetration & Growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Immunoassay Instruments Market product outlook key takeaways
FIG. 16 Immunoassay Instruments: Product movement analysis
FIG. 17 Chemilumenscence Immunoassay Market, 2014 - 2024 (USD Million)
FIG. 18 Immunofluorescence analyzers Market, 2014 - 2024 (USD Million)
FIG. 19 Radioimmunoassay Market, 2014 - 2024 (USD Million)
FIG. 20 Enzyme Linked Immunoassay Market, 2014 - 2024 (USD Million)
FIG. 21 Consumables Market, 2014 - 2024 (USD Million)
FIG. 22 Immunoassay Instruments market Application outlook key takeaways
FIG. 23 Immunoassay Instruments: Application movement analysis
FIG. 24 Therapeutic Drug Monitoring Market, 2014 - 2024 (USD Million)
FIG. 25 Oncology Market, 2014 - 2024 (USD Million)
FIG. 26 Cardiology Market, 2014 - 2024 (USD Million)
FIG. 27 Endocrinology Market, 2014 - 2024 (USD Million)
FIG. 28 Infectious Disease Testing Market, 2014 - 2024 (USD Million)
FIG. 29 Autoimmune Disease Market, 2014 - 2024 (USD Million)
FIG. 30 Other Applications Market, 2014 - 2024 (USD Million)
FIG. 31 Regional market place: Key takeaways
FIG. 32 Strategy framework
FIG. 33 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.